H. Prosch (Wien, Austria), L. Zanol Lorencini Stanzani (Lisbon, Portugal)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
The utility of the Gho scale in the tomographic evaluation of severe COVID 19 and its correlation with biomarkers.
A. Vega-Sanchez (Ciudad de Mexico, Mexico), M. Mejía (Ciudad de Mexico, Mexico), D. García-Estudillo (Ciudad de Mexico, Mexico), J. Rojas-Serrano (Ciudad de Mexico, Mexico), H. Mateos-Toledo (Ciudad de Mexico, Mexico), A. Estrada-Garrido (Ciudad de Mexico, Mexico), J. Castillo-Pedroza (Ciudad de Mexico, Mexico), P. Rivera-Matias (Ciudad de Mexico, Mexico)
|  |
Label-free analysis of experimental lung fibrosis using multiphoton microscopy and Raman spectroscopy
I. Ganzleben (Erlangen, Germany), L. Kreiß (Erlangen, Germany), A. Mühlberg (Erlangen, Germany), O. Friedrich (Erlangen, Germany), M. Neurath (Erlangen, Germany), S. Schürmann (Erlangen, Germany), M. Waldner (Erlangen, Germany)
|  |
The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy
C. Strange (Charleston, United States of America), N. Mcelvaney (Dublin, Ireland), C. Vogelmeier (Marburg, Germany), M. Marin-Galiano (Düsseldorf, Germany), M. Haensel (Marburg, Germany), X. Zhang (King of Prussia, United States of America), Y. Chen (King of Prussia, United States of America), O. Vit (Bern, Switzerland), M. Wencker (Loerzweiler, Germany), K. Chapman (Toronto, Canada)
| |
Proton MRI assessment of lung structure and function in people with cystic fibrosis
J. Brooke (Nottingham, United Kingdom), S. Safavi (Nottingham, United Kingdom), A. Prayle (Nottingham, United Kingdom), C. Ng (Nottingham, United Kingdom), J. Paul (Nottingham, United Kingdom), C. Bradley (Nottingham, United Kingdom), A. Cooper (Nottingham, United Kingdom), S. Munidasa (Toronto, Canada), B. Zanette (Toronto, Canada), G. Santyr (Toronto, Canada), H. Barr (Nottingham, United Kingdom), G. Major (Nottingham, United Kingdom), A. Smyth (Nottingham, United Kingdom), P. Gowland (Nottingham, United Kingdom), S. Francis (Nottingham, United Kingdom), I. Hall (Nottingham, United Kingdom)
| |
The severity of lung involvement in systemic sclerosis expressed as a Warrick score differs depending on the HRCT scan procedure
Ö. Emilsson (Uppsala, Sweden), A. Dessle (Uppsala, Sweden), H. Johansson (Uppsala, Sweden), S. Adeli (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden), M. Eloranta (Uppsala, Sweden), T. Hansen (Uppsala, Sweden)
| |
Innovative application of artificial intelligence to pre-screen COVID-19 from digital chest radiographs – our experience in a tertiary care setup
P. Ajmera (Pune, India), A. Kharat (Pune, India), D. Patkar (Mumbai, India), M. Verma (Mumbai, India)
| |
Imaging Ventilation In Awake Non-sedated Pre-school Children With Free-Breathing Upright Proton MRI.
J. Harkin (Nottingham, United Kingdom), A. Cooper (Nottingham, United Kingdom), M. Barlow (Nottingham, United Kingdom), S. Safavi (Nottingham, United Kingdom), P. Gowland (Nottingham, United Kingdom), A. Smyth (Nottingham, United Kingdom), I. Hall (Nottingham, United Kingdom), A. Prayle (Nottingham, United Kingdom)
| |
Late Breaking Abstract - Prognostic value of pulmonary artery diameter as a measure of right ventricular strain in hospitalized Covid-19 patients
M. Riachy (Beirut, Lebanon), F. Farah (Beirut, Lebanon), M. Awali (Beirut, Lebanon), A. Ismail (Beirut, Lebanon), N. Aoun (Beirut, Lebanon), A. Riachy (Beirut, Lebanon), E. Mekhael (Beirut, Lebanon), K. El Hoyek (Beirut, Lebanon), N. Nassim (Beirut, Lebanon), G. Sleilaty (Beirut, Lebanon)
| |
Late Breaking Abstract - Digital tomography in the diagnosis of a posterior pneumothorax in the intensive care unit (ICU)
S. Wellekens (Brussel, Belgium), J. Jonckheer (Brussel, Belgium), N. Buls (Brussel, Belgium), J. De Mey (Brussel, Belgium)
| |
A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH)
S. Alabed (Sheffield, United Kingdom), K. Karunasaagarar (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), M. Salehi (Sheffield, United Kingdom), Z. Aldabbagh (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), J. Uthoff (Sheffield, United Kingdom), H. Lu (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom), R. Van Der Geest (Leiden, Netherlands), A. Swift (Sheffield, United Kingdom)
| |
The correlation between the results of 99m Tc-technetril accumulation and MSCT data in granulomatous lung diseases
R. Amansahedov (Moscow, Russian Federation), E. Vasilenko (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), A. Sigaev (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |
Prognostic impact of pleuropulmonary pathologies in the early phase of acute pancreatitis.
I. Luiken (Halle (Saale), Germany), S. Eisenmann (Halle (Saale), Germany), J. Garbe (Halle (Saale), Germany), J. Dober (Halle (Saale), Germany), W. Wohlgemuth (Halle (Saale), Germany), R. Brill (Halle (Saale), Germany), P. Michl (Halle (Saale), Germany), J. Rosendahl (Halle (Saale), Germany), M. Damm (Halle (Saale), Germany)
| |
Artificial intelligence to optimize pulmonary embolism diagnosis during covid-19 pandemic by perfusion SPECT/CT, a pilot study
S. Baeza (Badalona, Spain), R. Domingo (Bellaterra, Spain), M. Salcedo-Pujantell (Badalona, Spain), J. Deportós (Badalona, Spain), G. Moragas (Badalona, Spain), I. Garcia-Olivé (Badalona, Spain), C. Sanchez (Bellaterra, Spain), D. Gil (Bellaterra, Spain), A. Rosell (Badalona, Spain)
| |
A retrospective study comparing a quantifying Artificial Intelligence-based scoring system with a visual scoring system to determine the lung injury in COVID-19 disease.
C. Biebaû (Leuven, Belgium), A. Dubbeldam (Leuven, Belgium), L. Cockmartin (Leuven, Belgium), W. Coudyzer (Leuven, Belgium), J. Coolen (Leuven, Belgium), J. Verschakelen (Leuven, Belgium), W. De Wever (Leuven, Belgium)
| |
Prediction of outcome in COVID-19 patients based on clinical and radiomics chest CT data
J. Guiot (Liege, Belgium), A. Vaidyanathan (Liege, Belgium), F. Zerka (Liege, Belgium), L. Deprez (Liege, Belgium), D. Danthine (Liege, Belgium), A. Frix (Liege, Belgium), F. Bottari (Liege, Belgium), M. Henket (Liege, Belgium), S. Mathieu (Liege, Belgium), P. Lambin (Maastricht, Netherlands), S. Walsh (Liege, Belgium), M. Occhipinti (Liege, Belgium), B. Misset (Liege, Belgium), L. Renard (Liege, Belgium), P. Meunier (Liege, Belgium), W. Vos (Liege, Belgium), R. Leijenaar (Liege, Belgium), P. Lovinfosse (Liege, Belgium), This Work Has Received Support From The Eu/efpia Innovative Medicines Initiative 2 Joint Undertaking Dragon Grant N° No 101005122 (Liege, Belgium)
| |
Validation of remote dielectric sensing (ReDS) in COVID-19
F. Mei (Ancona (AN), Italy), A. Di Marco Berardino (Ancona (AN), Italy), M. Bonifazi (Ancona (AN), Italy), L. Latini (Ancona (AN), Italy), L. Zuccatosta (Ancona (AN), Italy), S. Gasparini (Ancona (AN), Italy)
| |
Role of adaptive immunity in clinical variability of active tuberculosis patients
C. Quarato (Foggia, Italy), G. Scioscia (Foggia, Italy), D. Lacedonia (Foggia, Italy), K. Del Vecchio (Foggia, Italy), A. Laricchiuta (Foggia, Italy), M. Colanardi (Foggia, Italy), E. Giuffreda (Foggia, Italy), P. Bonfitto (Foggia, Italy), M. Foschino Barbaro (Foggia, Italy)
| |